Barbara Mair

Barbara Mair

Auto-generated profile, based on publicly available information

Barbara Mair

Donnelly Centre, University of Toronto; Toronto ON

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2013 in Nature
Verified
Journal Article
Closed access
PDF file
THToshikatsu Hanada
Toshikatsu Hanada
SWStefan Weitzer
Stefan Weitzer
BMBarbara Mair
Barbara Mair
CBChristian Bernreuther
Christian Bernreuther
BWBrian J. Wainger
Brian J. Wainger
JPJosef M Penninger
Josef M Penninger

1 March 2019 in Cell
Verified
Journal Article
Closed access
MCMichael Costanzo
Michael Costanzo
EKElena Kuzmin
Elena Kuzmin
JLJolanda van Leeuwen
Jolanda van Leeuwen
BMBarbara Mair
Barbara Mair
JMJason Moffat
Jason Moffat
BABrenda Andrews
Brenda Andrews

10 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
CKChristiane Kofink
Christiane Kofink
NTNicole Trainor
Nicole Trainor
BMBarbara Mair
Barbara Mair
SWSimon Wöhrle
Simon Wöhrle
MWMelanie Wurm
Melanie Wurm
WFWilliam Farnaby
William Farnaby
Targeted protein degradation offers an alternative modality to classical inhibition and holds the promise of addressing previously undruggable targets to provide novel therapeutic options for patients. Heterobifunctional molecules co-recruit a target protein and an E3 ligase, resulting in ubiquitylation and proteosome-dependent degradation of the target. In the clinic, the oral route of administration is the option of choice but has only been achieved so far by CRBN- recruiting bifunctional degrader molecules. We aimed to achieve orally bioavailable molecules that selectively degrade the BAF Chromatin Remodelling complex ATPase SMARCA2 over its closely related paralogue SMARCA4, to allow in vivo evaluation of the synthetic lethality concept of SMARCA2 dependency in SMARCA4-deficient cancers. Here we outline structure- and property-guided approaches that led to orally bioavailable VHL-recruiting degraders. Our tool compound, ACBI2, shows selective degradation of SMARCA2 over SMARCA4 in ex vivo human whole blood assays and in vivo efficacy in SMARCA4-deficient cancer models. This study demonstrates the feasibility for broadening the E3 ligase and physicochemical space that can be utilised for achieving oral efficacy with bifunctional molecules.

11 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
JLJulian Lamanna
Julian Lamanna
ESErica Y. Scott
Erica Y. Scott
HEHarrison S. Edwards
Harrison S. Edwards
MCM. Dean Chamberlain
M. Dean Chamberlain
MDMichael D. M. Dryden
Michael D. M. Dryden
AWAaron R. Wheeler
Aaron R. Wheeler
We introduce Digital microfluidic Isolation of Single Cells for -Omics (DISCO), a platform that allows users to select particular cells of interest from a limited initial sample size and connects single-cell sequencing data to their immunofluorescence-based phenotypes. Specifically, DISCO combines digital microfluidics, laser cell lysis, and artificial intelligence-driven image processing to collect the contents of single cells from heterogeneous populations, followed by analysis of single-cell genomes and transcriptomes by next-generation sequencing, and proteomes by nanoflow liquid chromatography and tandem mass spectrometry. The results described herein confirm the utility of DISCO for sequencing at levels that are equivalent to or enhanced relative to the state of the art, capable of identifying features at the level of single nucleotide variations. The unique levels of selectivity, context, and accountability of DISCO suggest potential utility for deep analysis of any rare cell population with contextual dependencies.

1 April 2019 in Cell Reports
Verified
Journal Article
Open access
BMBarbara Mair
Barbara Mair
JTJelena Tomic
Jelena Tomic
SMSanna N. Masud
Sanna N. Masud
PTPeter Tonge
Peter Tonge
AWAlexander Weiss
Alexander Weiss
JMJason Moffat
Jason Moffat
Human pluripotent stem cells (hPSCs) provide an invaluable tool for modeling diseases and hold promise for regenerative medicine. For understanding pluripotency and lineage differentiation mechanisms, a critical first step involves systematically cataloging essential genes (EGs) that are indispensable for hPSC fitness, defined as cell reproduction in this study. To map essential genetic determinants of hPSC fitness, we performed genome-scale loss-of-function screens in an inducible Cas9 H1 hPSC line cultured on feeder cells and laminin to identify EGs. Among these, we found FOXH1 and VENTX, genes that encode transcription factors previously implicated in stem cell biology, as well as an uncharacterized gene, C22orf43/DRICH1. hPSC EGs are substantially different from other human model cell lines, and EGs in hPSCs are highly context dependent with respect to different growth substrates. Our CRISPR screens establish parameters for genome-wide screens in hPSCs, which will facilitate the characterization of unappreciated genetic regulators of hPSC biology.

8 December 2022 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
AVAnne-Laure Valton
Anne-Laure Valton
SVSergey V. Venev
Sergey V. Venev
BMBarbara Mair
Barbara Mair
EKEraj Shafiq Khokhar
Eraj Shafiq Khokhar
ATAmy H. Y. Tong
Amy H. Y. Tong
JDJob Dekker
Job Dekker